Leptin receptor, human
Leptin is an important regulator of energy balance, food intake, and body weight.
The leptin receptor is expressed in various tissues, including the hypothalamus, where it mediates leptin's effects on appetite and metabolism.
Proper functioning of the leptin receptor is crucial for maintaining normal body weight and energy homeostasis.
Disfunctions in the leptin recepotr pathway have been implicated in obesity and related metabolic disorders.
Most cited protocols related to «Leptin receptor, human»
positional cloning approach and the comparative transfer approach were used to target various
gene families for discovery of gene networks associated with economically important traits in
beef cattle. A total of 71 genes that had mutations detected and genotyped successfully in our
beef reference population (see Animals, Phenotypes and Statistical Analysis) are illustrated in
Figure
classified into five gene families.
The first family involves nuclear encoded mitochondrial genes, such as aldehyde dehydrogenase
4 family, member A1 (ALDH4A1), amyloid beta (A4) precursor protein
(APP), ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit
(ATP5O), BCL2-antagonist/killer 1 (BAK1), chromosome 21 open
reading frame 2 (C21orf2), collagen, type VI, alpha 1
(COL6A1), C-reactive protein, pentraxin-related (CRP),
enhancer of yellow 2 homolog (Drosophila) (ENY2), fatty acid binding protein 3
(FABP3) 5 (link), fatty acid binding protein 4
(FABP4) 6 (link), mitochondrial fission
regulator 1 (MTFR1), mitochondrial ribosomal protein L39
(MRPL39), polymerase (RNA) mitochondrial (DNA directed)
(POLRMT), Poly (A) polymerase associated domain containing 1
(PAPD1) 7 (link), RAB2A, member RAS oncogene
family (RAB2A), regulator of calcineurin 1 (RCAN1),
single-minded homolog 2 (Drosophila) (SIM2), superkiller viralicidic activity
2-like (S. cerevisiae) (SKIV2L), transcription factor A, mitochondrial
(TFAM) 8 (link), transcription factor B1,
mitochondrial (TFB1M), transcription factor B2, mitochondrial
(TFB2M), tumor necrosis factor (TNF superfamily, member 2)
(TNF), ubiquinol-cytochrome c reductase core protein I
(UQCRC1) 9 (link) and uncoupling protein 1
(UCP1).
The second family is related to the long chain fatty acids uptake gene complex, including
solute carrier family 2, member 2 (SLC2A2), solute carrier family 25, member 27
(SLC25A27) and solute carrier family 27, member 1 (SLC27A1),
member 2 (SLC27A2) and member 4 (SLC27A4).
The third family deals with the sauvagine/corticotropin-releasing factor/urotensin I family
and related families, such as corticotropin releasing hormone (CRH) 10 (link), CRH receptor 1 (CRHR1), CRH receptor 2
(CRHR2) 11 (link), urocortin 3
(UCN3), urotensin 2 (UTS2) and urotensin 2 receptor
(UTS2R) 12 (link).
The fourth family targets the lipogenesis/lipolysis enzymes, such as acetyl-Coenzyme A
acetyltransferase 2 (ACAT2), acyl-CoA synthetase long-chain family member 5
(ACSL5), 7-dehydrocholesterol reductase (DHCR7),
diacylglycerol O-acyltransferase homolog 1 (DGAT1) 5 (link), fibronectin type III domain containing 3B (FNDC3B),
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 (soluble) (HMGCS1),
3-hydroxymethyl-3-methylglutaryl-Coenzyme A lyase (HMGCL), lipase,
hormone-sensitive (LIPE), patatin-like phospholipase domain containing 2
(PNPLA2), stearoyl-CoA desaturase (delta-9-desaturase) (SCD1)
13 (link) and sterol O-acyltransferase 1
(SOAT1).
The fifth family focuses on calpain/calpasatin or related genes, such as calpain 1
(CAPN1), calpain 3 (CAPN3), calpain 5
(CAPN5), calpain 7 (CAPN7), calpain 8
(CAPN8), calpain 9 (CAPN9), calpain 11
(CAPN11), calpain 12 (CAPN12), calpain 14
(CAPN14), calpain, small subunit 1 (CAPNS1), calpastatin
(CAST) 14 (link), dermatopontin
(DPT), neuromedin U (NMU), troponin I type 2 (skeletal, fast)
(TNNI2) and troponin T type 1 (skeletal, slow) (TNNT1).
In addition, ankyrin repeat and SOCS box-containing 3 (ASB3), chromodomain
helicase DNA binding protein 9 (CHD9), dopey family member 2
(DOPEY2), epidermal growth factor receptor pathway substrate 15
(EPS15), growth hormone 1 (GH1), histone cluster 1, H1t
(HIST1H1T), leptin (LEP), proteasome (prosome, macropain)
assembly chaperone 1 (PSMG1), thyroglobulin (TG) and tRNA
nucleotidyl transferase, CCA-adding, 1 (TRNT1) were also investigated in the
present study.
sequences for the candidate genes described above. We used cDNA sequences of the human orthologs
as references for BLAST searches to retrieve the orthologous cDNA sequences against the GenBank
database “nr” or the orthologous ESTs sequences against the GenBank database
“est_others” with a species option limited to Bos taurus.
The cDNA sequences in the “nr” database represent three categories: cDNA
sequences derived from a full-length cDNA library, known gene cDNA sequences or annotated cDNA
sequences compiled by the GenBank staff. We collected the longest cDNA sequence retrieved from
the “nr” database or a cDNA sequence assembled from several ESTs retrieved
from the “est_others” database to form a primary cDNA sequence for each
cattle gene. This sequence was then used to perform a species-specific BLAST search against the
“est_others” database in order to expand the primary sequence to a
full-length cDNA sequence. At the end, we used the full-length cDNA sequence to search for
genomic DNA contigs in the 7.15X bovine genome sequence database (see the Bovine Genome
Resources at NCBI). The cDNA sequences and genomic DNA sequences were aligned to
determine the genomic organizations of all genes investigated in the present study.
The online oligonucleotide design tool Primer3 (
following criteria: 18-25 bp in length, >50% in GC content and optimal Tm of either
60oC or 65oC. We mainly targeted the promoter region and the
3'untranslated region (UTR) of each gene to maximize the chance for mutation detection. The
sizes of the amplified products for most amplicons ranged from 400 - 600 bp, which is a
sufficient length for accurate sequencing analysis. PCR reactions were performed using 25 ng of
bovine genomic DNA as template in a final volume of 10 μL containing 12.5 ng of each
primer, 200 μM dNTPs, 1.5 - 3 mM MgCl2, 50 mM KCl, 20 mM Tris-HCl and 0.2U
of Platinum Taq polymerase (Invitrogen, Carlsbad, CA). The PCR conditions were carried out as
follows: 94oC for 2 min, 32 cycles of 94oC for 30 sec, 61oC for
30 sec and 72oC for 30 sec, followed by a further 5 min extension at 72oC.
PCR products were examined by electrophoresis through a 1.5% agarose gel with 1X TBE buffer to
determine the quality and quantity for DNA sequencing. Sequencing was performed on ABI 3730
sequencer in the Laboratory for Biotechnology and Bioanalysis (Washington State University).
Mutations were identified using six Wagyu-Limousin F1 animals (see animals below) and
138 of them were successfully genotyped on all animals using a Sequenom iPLEX assay service
provided by the Children's Hospital Oakland Research Institute, Oakland, California.
including 6 F1 bull, 113 F1 dams and 246 F2 progeny. We focused
on a total of 19 phenotypic measurements, which can be classified into three categories: carcass
measurements, including carcass weight (CW), ribeye area (REA), subcutaneous fat depth (SFD),
percentage of kidney, pelvic and heart fat (KPH) and beef marbling scores (BMS); eating quality,
including shear force of cooked steak (SFCS), taste panel myofibrillar tenderness (TPMT), taste
panel connective tissue (TPCT) content, taste panel overall tenderness (TPOT) rating, taste
panel juiciness (TPJN), taste panel flavor evaluation (TPFE); and fatty acid composition
including three indexes of Δ9 desaturase activity - R1 = 14:1 to
14:0, R2 = 16:1 to 16:0 and R3 = 18:1 to 18:0, relative amounts of
saturated (SFA), monounsaturated (MUFA) and poly unsaturated fatty acids (PUFA), conjugated
linoleic acid/100 g dry meat (CLA) and cholesterol/100 g dry meat (CHOL). Development/management
of the Wagyu-Limousin reference population and measurement/definition of these phenotypes were
described previously 8 (link),15 (link)-18 .
The HAPLOVIEW program 19 (link) was used to determine the
linkage disequilibrium (LD) of 138 markers located on 22 bovine chromosomes, thus leading to
selection of tag mutations for association analysis. The association between genotypes and
traits was evaluated using the general linear model (GLM) procedure of SPSS (version 16.0) (The
Predictive Analytic Company, Chicago, USA). The model was:
where yijklm is phenotypic observation of a quantitative trait for
animal m, sexi is the effect of the i-th sex
category (i=1,2), yearj is the effect of the j-th
harvest year (j=1,2), age is a covariate for age in days of
the animal at harvest, snpk represents the effects of each genotype
at the k-th SNP locus, and sirel is random effect of the l-th sire
producing animal m, and eijklm is a residual term
pertaining to animal m. In the model, we assumed that where is the variance of
sire effects, and A is an additive genetic relationship matrix among the sires, and
where
is
the residual variance. If the effects of sire, sex, year, or age were not significant
(P>0.05) after initial analysis, they were removed from the model for final analysis.
All single marker-trait associations that reached a significance level of P<0.05 were
initially included in further analysis. We discarded significant markers when there were 9 or
fewer animals in one genotype group or there were only two genotypes rather than three. Based on
the pairwise significance tests among three genotypes, we classified the remaining significant
associations into three quantitative trait modes (QTMs): 1) additive mode when PAa ≈ (PAA + Paa)/2; 2) dominant mode when PAa ≈ either PAA or Paa; and 3) overdominant mode when
PAa > or < both PAA and Paa, where
PAa = least square means of heterozygous animals, PAA = least square means
of homozygous animals with higher performance and Paa = least square means of
homozygous animals with lower performance. We then integrated these markers along with their
QTMs into a linear regression analysis using the linear regression procedure (SPSS for Windows,
version 16.0) in order to identify gene-gene combinations, i.e., gene-networks related to
carcass traits, eating quality and fatty acid composition in beef.
Antibodies used in the study.
Signaling proteins | No. | Antibodies |
---|---|---|
Cellular proliferation | 10 | Ki-67 |
cMyc/MAX/MAD signaling | 3 | cMyc*, MAX |
p53/Rb/E2F signaling | 5 (2) | p53, Rb-1#, E2F-1*, (p21, CDK4) |
Wnt/β-catenin signaling | 5 | Wnt1*, β-catenin*, APC*, snail*, TCF-1* |
Epigenetic modification | 6 | DMAP1 |
Protein translation signaling | 5 | DOHH |
RAS signaling | 17 | NRAS$, KRAS$, STAT3*, SOS-1 |
Growth factor signaling | 16 | FGF-1 |
NFkB signaling | 12 (3) | NFkB |
Upregulated inflammatory proteins | 26 (2) | IL-12 |
Downregulated inflammatory proteins | 13 (1) | TNFα@, IL-1 |
Cellular protection-related | 15 (2) | LC3, PLC- β2, PI3K, PKC |
Antioxidant-related | 8 (3) | HO-1 |
p53-mediated cellular apoptosis | 17 (1) | (p53*), PUMA |
FAS-mediated cellular apoptosis | 8 (3) | FASL |
Oncogenic proteins | 15 (2) | PTEN&, MUC1, MUC4, maspin*, BRCA1&, BRCA2&, NF-1 |
Angiogenesis-related proteins | 20 (7) | HIF&, VEGF-A |
Osteogenesis-related proteins | 12 (2) | OPG |
Control housekeeping proteins | 3 | α-tubulin*, β-actin |
Total | 216 (28) |
*Santa Cruz Biotechnology, USA; #DAKO, Denmark; $Neomarkers, CA, USA; @ZYMED, CA, USA; &Abcam, Cambridge, UK; the number of antibodies overlapped; ().
Abbreviations: AMPK; AMP-activated protein kinase, pAKT; v-akt murine thymoma viral oncogene homolog, p-Akt1/2/3 phosphorylated (p-Akt, Thr 308), APAF-1; apoptotic protease-activating factor 1, AP-1; activating protein-1, BAD; BCL2 associated death promoter, BAK; BCL2 antagonist/killer, BAX; BCL2 associated X, BCL-2; B-cell leukemia/lymphoma-2, BID; BH3 interacting-domain death agonist, c-caspase 3; cleaved-caspase 3, CD3; cluster of differentiation 3, CDK4; cyclin dependent kinase 4, CEA; carcinoembryonic antigen, CMG2: capillary morphogenesis protein 2, COX-1; cyclooxygenase-2, COX-2; cyclooxygenase-2, c-PARP; cleaved- PARP (poly-ADP ribose polymerase), DMAP1; DNA methyltransferase 1 associated protein, DMBT1; deleted in malignant brain tumors 1, DOHH; deoxyhypusine hydroxylase, DHS; deoxyhypusine synthase, E2F-1; transcription factor, eIF2AK3 (PERK); eukaryotic translation initiation factor 2 (protein kinase R (PKR)-like endoplasmic reticulum kinase), elF5A-1; eukaryotic translation initiation factor 5A-1, elF5A-2; eukaryotic translation initiation factor 5A-2, ERβ; estrogen receptor beta, ERK; extracellular signal-regulated protein kinases, ET-1: endothelin-1, FAS; CD95/Apo1, FASL; FAS ligand, FADD; FAS associated via death domain, FGF-1; fibroblast growth factor-1, FLIP; FLICE-like inhibitory protein, FLT-4; Fms-related tyrosine kinase 4, GADD45; growth arrest and DNA-damage-inducible 45, GAPDH; glyceraldehyde 3-phosphate dehydrogenase, GH; growth hormone, GHRH; growth hormone-releasing hormone, GST-1; glutathione S-transferase ω 1, HDAC-10; histone deacetylase 10, HIF-1α: hypoxia inducible factor-1α, HO-1; heme oxygenase 1, HER1; human epidermal growth factor receptor 1, HGFα; hepatocyte growth factor α, HSP-70; heat shock protein-70, IKK; ikappaB kinase, IGF-1; insulin-like growth factor 1, IGFIIR; insulin-like growth factor 2 receptor, IgK; immunoglobulin kappa (light chain), IL-1; interleukin-1, KDM4D; Lysine-specific demethylase 4D, JNK-1; Jun N-terminal protein kinase, KRAS; V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog, LC3; microtubule-associated protein 1 A/1B-light chain 3, LYVE-1: lymphatic vessel endothelial hyaluronan receptor 1, MAX; myc-associated factor X, MBD4; methyl-CpG-binding domain protein 4, M-CSF; macrophage colony-stimulating factor, MDM2; mouse double minute 2 homolog, MDR; multiple drug resistance, MMP-1; matrix metalloprotease-1, MPM2; mitotic protein monoclonal 2, mTOR; mammalian target of rapamycin, cMyc; V-myc myelocytomatosis viral oncogene homolog, NFkB; nuclear factor kappa-light-chain-enhancer of activated B cells, NOS-1; nitric oxide synthase 1, NRAS; neuroblastoma RAS Viral Oncogene homolog, NRF2; nuclear factor (erythroid-derived)-like 2, p14, p16, p21, p27, p38, PAI-1; plasminogen activator inhibitor-1, PARP; poly-ADP ribose polymerase, PCNA; proliferating cell nuclear antigen, PDGF-A: platelet-derived growth factor-A, PLC-β2; 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterse β-2, PI3K; phosphatidylinositol-3-kinase, PLK4; polo like kinase 4 or serine/threonine-protein kinase, PKC; protein kinase C, p-p38; phosphor-p38, PTEN; phosphatase and tensin homolog, RANKL; receptor activator of nuclear factor kappa-B ligand, Rb-1; retinoblastoma-1, RUNX2; Runt-related transcription factor-2, SMAD4; mothers against decapentaplegic, drosophila homolog 4, SOD-1; superoxide dismutase-1, SP-1; specificity protein 1, STAT3; signal transducer and activator of transcription-3, TGF-β1; transforming growth factor-β1, TERT; human telomerase reverse transcriptase, TNFα; tumor necrosis factor-α, β-actin, 14-3-3, VEGF vascular endothelial growth factor, VEGFR2: vascular endothelial growth factor receptor 2, p-VEGFR2: vascular endothelial growth factor receptor 2 (Y951), vWF: von Willebrand factor.
The expressions of housekeeping proteins, that is, β-actin, α-tubulin, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were used as internal controls. Expressional changes of housekeeping proteins were adjusted to <±5% using a proportional basal line algorithm. To describe protein expressional changes, we tentatively defined a ≤±5% change as minimal, ±5–10% as slight, ±10–20% as meaningful, and a ≥±20% change as marked.
Most recents protocols related to «Leptin receptor, human»
The structure provides insights into the interaction between the ghrelin receptor and its ligands, Ghrelin, and a synthetic agonist. The ligands bind to specific regions on the ghrelin receptor, triggering a cascade of signaling events that regulate cellular responses 16 . Leptin is a cytokine crucial in regulating body weight and energy balance. Mutations in the gene encoding leptin or its receptor can lead to obesity, infertility, and diabetes in mice. The crystal structure of the mutant form of human leptin (leptin-E100) was determined using Xray diffraction. The resolution of the structure is 2.40 Å, which provides detailed information about the arrangement of atoms in the protein.
Top products related to «Leptin receptor, human»
More about "Leptin receptor, human"
Leptin is a key regulator of energy balance, food intake, and body weight.
The leptin receptor is expressed in various tissues, particularly the hypothalamus, where it mediates leptin's effects on appetite and metabolism.
Proper functioning of the leptin receptor is essential for maintaining normal body weight and energy homeostasis.
Dysfunctions in the leptin receptor pathway have been implicated in obesity and related metabolic disorders.
Recombinant human leptin, which mimics the structure and function of natural leptin, is a valuable tool for studying the leptin receptor and its signaling pathways.
Prism 6, a data analysis software, can be used to visualize and interpret the results of leptin receptor research.
Leptin and LEPR antibodies are also commonly used to detect and quantify the expression of the leptin receptor in different cell types and tissues.
Cell culture experiments investigating the leptin receptor often utilize fetal bovine serum (FBS) as a growth supplement.
The Cell Counting Kit-8 (CCK-8) is a convenient method for assessing cell viability and proliferation in these experiments.
Additionally, the Bicinchoninic acid (BCA) protein assay kit can be used to measure the total protein content in cell lysates, which is important for normalizing experimental data.
The Hoechst 33258 dye is a fluorescent stain that can be used to visualize and quantify the nuclei of cells, providing insights into cellular processes related to the leptin receptor.
By incorporating these related terms, abbreviations, and experimental techniques, researchers can optimize their leptin receptor studies for enhanced reproducibility and accuracy, as highlighted by the Metadescription of PubCompare.ai.
This comprehensive understanding of the leptin receptor and its associated tools and methodologies can lead to more reliable and informative results in the pursuit of understanding obesity and related metabolic disorders.